Vitaspring Biomedical VSBC
OTC VSBC
$0.01 +0.00 (+0.00%)
At close: Sep 25, 2026 · 4:00 PM EDT

Vitaspring Biomedical (VSBC) EV to EBITDA (2022)

Updated

Vitaspring Biomedical's (VSBC) EV to EBITDA was 2159.82 for fiscal Q3 2023 (quarter ended Oct 31, 2022), up 10.3% from the prior quarter.

Analysis

Vitaspring Biomedical (VSBC) EV to EBITDA (2022) Analysis & Trends

Over the twelve months ended Oct 31, 2022, Vitaspring Biomedical's EV to EBITDA came in at 2159.67; for FY2022 (ended Jan 31, 2022), it was 2547.35.

  • By fiscal year, EV to EBITDA came in at 2985.26 in FY2020.
  • Five-year quarterly EV to EBITDA spans a low of 1957.71 in fiscal Q2 2023 and a high of 2435.90 in fiscal Q4 2022.
  • Per Business Quant data, the three fiscal quarters before Q3 2023 came in at 1957.71 (Q2 2023), 1978.63 (Q1 2023) and 2435.90 (Q4 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Vitaspring Biomedical 2.07 Mn 2.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2022 2,159.82
Jul 31, 2022 1,957.71
Apr 30, 2022 1,978.63
Jan 31, 2022 2,435.90
API Access

Vitaspring Biomedical EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=VSBC&period=max&api_key=YOUR_API_KEY